Wallace Advisory Group LLC Has $859,000 Stock Position in Zoetis Inc. (NYSE:ZTS)

Wallace Advisory Group LLC cut its position in Zoetis Inc. (NYSE:ZTS) by 1.8% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 4,395 shares of the company’s stock after selling 81 shares during the quarter. Wallace Advisory Group LLC’s holdings in Zoetis were worth $859,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in ZTS. Belpointe Asset Management LLC increased its position in shares of Zoetis by 24.8% during the fourth quarter. Belpointe Asset Management LLC now owns 2,071 shares of the company’s stock worth $409,000 after acquiring an additional 412 shares in the last quarter. Exencial Wealth Advisors LLC boosted its position in shares of Zoetis by 8.9% during the fourth quarter. Exencial Wealth Advisors LLC now owns 3,130 shares of the company’s stock valued at $618,000 after buying an additional 257 shares during the last quarter. Morningstar Investment Services LLC bought a new stake in Zoetis during the fourth quarter worth $332,000. Prudential PLC lifted its stake in Zoetis by 1.1% during the 4th quarter. Prudential PLC now owns 33,260 shares of the company’s stock valued at $6,565,000 after acquiring an additional 377 shares in the last quarter. Finally, Waterloo Capital L.P. bought a new stake in shares of Zoetis in the 4th quarter worth $504,000. Institutional investors own 92.80% of the company’s stock.

Zoetis Stock Performance

NYSE ZTS traded down $0.96 on Friday, hitting $190.03. 1,697,760 shares of the stock traded hands, compared to its average volume of 2,576,563. The company has a debt-to-equity ratio of 1.32, a quick ratio of 2.09 and a current ratio of 3.45. The business’s fifty day moving average is $187.30 and its two-hundred day moving average is $175.45. Zoetis Inc. has a 12 month low of $144.80 and a 12 month high of $201.92. The firm has a market capitalization of $86.09 billion, a price-to-earnings ratio of 36.61, a PEG ratio of 2.95 and a beta of 0.89.

Zoetis (NYSE:ZTS) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.07. Zoetis had a return on equity of 50.67% and a net margin of 26.29%. The company had revenue of $2.36 billion during the quarter, compared to the consensus estimate of $2.31 billion. During the same quarter in the prior year, the company earned $1.41 EPS. The firm’s quarterly revenue was up 8.3% compared to the same quarter last year. As a group, equities analysts anticipate that Zoetis Inc. will post 5.84 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on ZTS. Piper Sandler raised their price target on shares of Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, August 14th. BTIG Research boosted their target price on Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, August 12th. Stifel Nicolaus increased their price target on Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research report on Wednesday, September 18th. Finally, Argus raised Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. Nine equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $220.38.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.